CLINICAL_TRIALS
research
· 2024-09-04
Clinical Trial Update: A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma [Phase 2]
Summary
A multicenter Phase II clinical trial evaluating zanubrutinib as maintenance therapy in patients with mantle cell lymphoma is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fudan University | Conditions: Mantle Cell Lymphoma, Maintenance Therapy | Phase 2 | Status: RECRUITING